Astec LifeSciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
January 25, 2024 at 04:47 pm IST
Share
Astec LifeSciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 507.95 million compared to INR 1,171.81 million a year ago. Revenue was INR 517.04 million compared to INR 1,209.7 million a year ago. Net loss was INR 243.34 million compared to net income of INR 8.4 million a year ago. Basic loss per share from continuing operations was INR 12.41 compared to basic earnings per share from continuing operations of INR 0.43 a year ago. Diluted loss per share from continuing operations was INR 12.41 compared to diluted earnings per share from continuing operations of INR 0.43 a year ago.
For the nine months, sales was INR 3,044.32 million compared to INR 5,011.94 million a year ago. Revenue was INR 3,080.29 million compared to INR 5,116.79 million a year ago. Net loss was INR 459.56 million compared to net income of INR 305.48 million a year ago. Basic loss per share from continuing operations was INR 23.44 compared to basic earnings per share from continuing operations of INR 15.58 a year ago. Diluted loss per share from continuing operations was INR 23.44 compared to diluted earnings per share from continuing operations of INR 15.58 a year ago.
Astec LifeSciences Limited is an India-based company that is primarily engaged in manufacturing a range of agrochemical active ingredients and pharmaceutical intermediates. The Company operates through the Agrochemicals segment. It manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Companyâs products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazaloneâs and heterocyclic sulfonyl chlorides.